WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Biopharma at Crossroads: A Mid-2025 Tale of Contradictions... The H12025 left China's biopharma sector standing in two worlds at once. On one side, dazzling headlines celebrated licensing deals worth billions, with Chinese ADCs and ...
(9/19/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

China Biopharma at Crossroads: A... (9/19/2025)

Gottlieb Cautions Blanket China Drug Licensing... (9/19/2025)

Obesity in China (The Lancet) (9/19/2025)

China's Biotechs Navigate the Demands of Inter... (9/19/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (9/18/2025)

Strengthening Oversight of Imported Drugs: Key... (9/18/2025)

Merger Control in China's Healthcare Industry:... (9/15/2025)

NHSA Issues the Regulations on DRG/DIP Healthc... (9/13/2025)

The Rise of US-China Biotech Partnerships: Opp... (9/12/2025)

U.S. Drugmakers Warn White House of Chaos as T... (9/10/2025)

MicuRx Plans Private Placement to Raise... (9/23/2025) KeyMed Initiates First Phase 3 Trial for... (9/23/2025) GenFleet Soars on HKSE Debut, Raising HK... (9/23/2025) IASO Bio Presents 36-Month Data for Fuca... (9/23/2025) Hangzhou Sciwind Biosciences Files for H... (9/23/2025) AusperBio Secures $63M Series B2 Financi... (9/22/2025) Ascletis' ASC47 Combined with Semaglutid... (9/22/2025) MagicRNA Publishes First-in-Human Data f... (9/22/2025) Study Compares Breakthru Therapy Designa... (9/22/2025) Leads Biolabs Wins FDA Clearance for IND... (9/22/2025) YolTech Raises $45M to Fund Its First Ph... (9/22/2025) Marengo Launches Combined Phase II Trial... (9/22/2025) Recent Executive Moves (9/20/2025) Ascletis and Sagimet's Acne Drug Demonst... (9/20/2025) China Produces Dozens of Drugs Below Mar... (9/19/2025) China Seeks Feedback on 2025 Draft Rule... (9/19/2025) China's Sharp API Price Cuts Jeopardize ... (9/19/2025) Lilly/Innovent's Mazdutide Approved in C... (9/19/2025)

China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am... China's Innovative Drug Market Surpasses CNY 400 Billio... China's 'Silver Yuan' Set to Power US$134B Boom in Geri...

Hangzhou Sciwind Biosciences Files for HKEX Listing GenFleet Soars on HKSE Debut, Raising HK$1.67B in Recor... MicuRx Plans Private Placement to Raise Up to ¥1B YolTech Raises $45M to Fund Its First Phase 3 CRISPR Tr... AusperBio Secures $63M Series B2 Financing

Study Compares Breakthru Therapy Designation Programs i... CDE Seeks Comments on Draft Guideline for Long-Acting L... CDE Issues Technical Requirements for AAV-Based In Vivo... China Seeks Feedback on 2025 Draft Rules for Drug Deve... China Seeks Feedback on New Guidelines for Adjuvanted V...

China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M... Aon Report Highlights Rapid Growth and Challenges in Ch... NHSA Announces Results of Form Review for 2025 NRDL Sub... China Unveils Nine Key Healthcare Insurance Priorities ...

Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C... U.S. Lawmakers Raise Fresh Alarm Over GenScript's China...

China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U.... India Moves to Set Minimum Import Prices to Protect Pha... China Struggles to Maintain Grip on India's Bulk Drug M... API China 2025 Ends with High Attendance and Global Ind...

IASO Bio Presents 36-Month Data for Fucaso KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb ... Marengo Launches Combined Phase II Trial of Invika and ... Leads Biolabs Wins FDA Clearance for IND of LBL-047 MagicRNA Publishes First-in-Human Data for In Vivo CAR-...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...